HopeStage
Back to all studies
CompletedNCT01409096

Pregnenolone or Placebo for Depression Related to Bipolarity

About this title

Study Using Pregnenolone to Treat Bipolar Depression

Read the official source — NCT01409096
Medication studyAges 18–75United States
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 75 years.

Listed locations
DallasSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateMarch 2010
Recruitment status
Completed
Enrollment listed in the registry
80
Sponsor
University of Texas Southwestern Medical Center
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States
Age range
From 18 Years to 75 Years
Official registry ID
NCT01409096
Official title
Show the full official title

A Randomized, Double Blind, Placebo-controlled Trial of Pregnenolone for Bipolar Depression

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Dallas

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of Texas Southwestern Medical Center, a university.

Did this study involve medication?

Yes. The study involved medication, including Pregnenolone and Placebo.

Who was this study for?

Listed age limits: 18 years to 75 years.

Want to explore more studies?

Explore studies